Tilron-L Tablet
Marketer
Avrohn Pharma I Limited
Salt Composition
Vildagliptin (50mg)
Overview Tilron-L Tablet
Glycemia-Control tablets are indicated for managing type 2 diabetes. Optimal blood glucose regulation requires concurrent adherence to a balanced diet and regular physical activity, mitigating the risk of severe diabetic complications such as renal impairment and vision loss. Prescribing Glycemia-Control typically occurs when dietary and exercise modifications, or other medications, prove inadequate for blood sugar management. Administration may be solitary or in conjunction with other antidiabetic agents, and can be taken with or without food. Dosage is individualized based on your clinical presentation and glycemic readings. Strict adherence to your physician's instructions is crucial. Consistent daily dosing at the same time maximizes therapeutic efficacy. Discontinuation should only occur under medical supervision. Continued commitment to the prescribed dietary and exercise regimen is essential. Lifestyle choices significantly impact diabetes control. Commonly reported adverse effects include hypoglycemia, tremors, cephalgia, vertigo, lassitude, and nausea. Recognizing hypoglycemic symptoms (e.g., lightheadedness, diaphoresis, vertigo, syncope, xerostomia) and appropriate management (e.g., glucose tablets) are vital. Persistent or concerning side effects necessitate immediate medical consultation. Prior to commencing treatment, disclose any history of renal, cardiac, or pancreatic conditions. Pregnant or lactating individuals must consult their doctor before initiating therapy. Potential drug interactions exist; therefore, complete medication disclosure to your physician is imperative. Alcohol consumption should be moderated, as it elevates hypoglycemic risk. Regular monitoring of renal function and blood glucose levels ensures therapeutic efficacy.
Primary Ingredients of Tilron-L Tablet
No text provided to rephrase.
Uses of Tilron-L Tablet
Managing type 2 diabetes
Major Benefits of Tilron-L Tablet:
Administer this medication precisely as prescribed by your physician, in terms of both dosage and treatment length. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Tilron-L Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Tilron-L Tablet:
- Hypoglycemia (low blood glucose level)
- Tremors
- Headache
- Dizziness
- Fatigue
- Nausea
How to use Tilron-L Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. You can take Tilron-L Tablet with or without food, but maintaining a consistent daily schedule is recommended.
How Tilron-L Tablet works:
Tilron-L tablets are used to manage diabetes. Their mechanism involves stimulating insulin secretion from the pancreas and suppressing counter-regulatory hormones that elevate blood glucose. This action consequently lowers both fasting and postprandial blood sugar concentrations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Tilron-L Tablet and alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Tilron-L Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Tilron-L Tablets while breastfeeding is likely inadvisable. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Tilron-L Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Tilron-L Tablets are generally considered safe for individuals with kidney disease, and dosage modification isn't usually necessary. Nevertheless, patients experiencing moderate to severe kidney impairment might need a modified dosage. Physician consultation is advised.
LiverUNSAFE
The use of Tilron-L Tablets is inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Tilron-L Tablet :
Should you forget a Tilron-L Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tilron-L Tablet
| Label | Value |
|---|---|
| Type of Compound | Pyrrolidinecarbonitrile compound |
| Potential for Dependence | None. |
| Medication Classification | Diabetes medication |
| Mechanism of Action | Dipeptidyl peptidase-4 inhibitors |
3,018 People bought this recently